These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19508400)

  • 1. 5-HT1A receptors are involved in the effects of xaliproden on G-protein activation, neurotransmitter release and nociception.
    Martel JC; Assié MB; Bardin L; Depoortère R; Cussac D; Newman-Tancredi A
    Br J Pharmacol; 2009 Sep; 158(1):232-42. PubMed ID: 19508400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT 1A agonist and D4 partial agonist properties. I. In vitro receptor affinity and efficacy profile.
    Newman-Tancredi A; Assié MB; Martel JC; Cosi C; Slot LB; Palmier C; Rauly-Lestienne I; Colpaert F; Vacher B; Cussac D
    Br J Pharmacol; 2007 May; 151(2):237-52. PubMed ID: 17375087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transduction and functional selectivity of F15599, a preferential post-synaptic 5-HT1A receptor agonist.
    Newman-Tancredi A; Martel JC; Assié MB; Buritova J; Lauressergues E; Cosi C; Heusler P; Bruins Slot L; Colpaert FC; Vacher B; Cussac D
    Br J Pharmacol; 2009 Jan; 156(2):338-53. PubMed ID: 19154445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924.
    Newman-Tancredi A; Rivet JM; Cussac D; Touzard M; Chaput C; Marini L; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Sep; 368(3):188-99. PubMed ID: 12923612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAPK activation via 5-hydroxytryptamine 1A receptor is involved in the neuroprotective effects of xaliproden.
    Appert-Collin A; Duong FH; Passilly Degrace P; Warter JM; Poindron P; Gies JP
    Int J Immunopathol Pharmacol; 2005; 18(1):21-31. PubMed ID: 15698508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SLV313 (1-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-4- [5-(4-fluoro-phenyl)-pyridin-3-ylmethyl]-piperazine monohydrochloride): a novel dopamine D2 receptor antagonist and 5-HT1A receptor agonist potential antipsychotic drug.
    McCreary AC; Glennon JC; Ashby CR; Meltzer HY; Li Z; Reinders JH; Hesselink MB; Long SK; Herremans AH; van Stuivenberg H; Feenstra RW; Kruse CG
    Neuropsychopharmacology; 2007 Jan; 32(1):78-94. PubMed ID: 16710314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of xaliproden, a 5-HT₁A agonist, on mechanical allodynia caused by chemotherapeutic agents in mice.
    Andoh T; Sakamoto A; Kuraishi Y
    Eur J Pharmacol; 2013 Dec; 721(1-3):231-6. PubMed ID: 24070812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xaliproden (SR57746A) induces 5-HT1A receptor-mediated MAP kinase activation in PC12 cells.
    Appert-Collin A; Duong FH; Passilly DeGrace P; Bennasroune A; Poindron P; Warter JM; Gies JP
    Int J Immunopathol Pharmacol; 2005; 18(2):233-44. PubMed ID: 15888246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding.
    Odagaki Y; Toyoshima R; Yamauchi T
    J Psychopharmacol; 2005 May; 19(3):235-41. PubMed ID: 15888508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NLX-112, a highly selective 5-HT
    Newman-Tancredi A; Bardin L; Auclair A; Colpaert F; Depoortère R; Varney MA
    Brain Res; 2018 Jun; 1688():1-7. PubMed ID: 29555239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT(1A) receptor-mediated Galpha(i3) activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling.
    Newman-Tancredi A; Cussac D; Marini L; Millan MJ
    Mol Pharmacol; 2002 Sep; 62(3):590-601. PubMed ID: 12181435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting contribution of 5-hydroxytryptamine 1A receptor activation to neurochemical profile of novel antipsychotics: frontocortical dopamine and hippocampal serotonin release in rat brain.
    Assié MB; Ravailhe V; Faucillon V; Newman-Tancredi A
    J Pharmacol Exp Ther; 2005 Oct; 315(1):265-72. PubMed ID: 15987834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y; Toyoshima R
    Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The 5HT(1A) receptor ligand, S15535, antagonises G-protein activation: a [35S]GTPgammaS and [3H]S15535 autoradiography study.
    Newman-Tancredi A; Rivet J; Chaput C; Touzard M; Verrièle L; Millan MJ
    Eur J Pharmacol; 1999 Nov; 384(2-3):111-21. PubMed ID: 10611431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine(1A) receptor-stimulated [(35)S]GTPgammaS binding in rat brain: absence of regional differences in coupling efficiency.
    Meller E; Li H; Carr KD; Hiller JM
    J Pharmacol Exp Ther; 2000 Feb; 292(2):684-91. PubMed ID: 10640306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profound, non-opioid analgesia produced by the high-efficacy 5-HT(1A) agonist F 13640 in the formalin model of tonic nociceptive pain.
    Bardin L; Tarayre JP; Malfetes N; Koek W; Colpaert FC
    Pharmacology; 2003 Apr; 67(4):182-94. PubMed ID: 12595749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulators of G-protein signaling 4: modulation of 5-HT1A-mediated neurotransmitter release in vivo.
    Beyer CE; Ghavami A; Lin Q; Sung A; Rhodes KJ; Dawson LA; Schechter LE; Young KH
    Brain Res; 2004 Oct; 1022(1-2):214-20. PubMed ID: 15353231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The putative <> 5-HT(1A) receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT(1A) receptors.
    Cosi C; Koek W
    Eur J Pharmacol; 2000 Jul; 401(1):9-15. PubMed ID: 10915831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.